nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—Topoisomerase Inhibitors—Irinotecan—pancreatic cancer	0.32	0.49	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Epirubicin—pancreatic cancer	0.173	0.265	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Doxorubicin—pancreatic cancer	0.16	0.245	CiPCiCtD
Mitoxantrone—TOP2A—Epirubicin—pancreatic cancer	0.0238	0.0957	CbGbCtD
Mitoxantrone—CYP1B1—Tamoxifen—pancreatic cancer	0.0235	0.0946	CbGbCtD
Mitoxantrone—CYP1B1—Erlotinib—pancreatic cancer	0.02	0.0805	CbGbCtD
Mitoxantrone—CYP1B1—Docetaxel—pancreatic cancer	0.0132	0.0532	CbGbCtD
Mitoxantrone—ABCC1—Epirubicin—pancreatic cancer	0.0132	0.0531	CbGbCtD
Mitoxantrone—ABCC1—Irinotecan—pancreatic cancer	0.0128	0.0516	CbGbCtD
Mitoxantrone—TOP2A—Doxorubicin—pancreatic cancer	0.0126	0.0509	CbGbCtD
Mitoxantrone—ABCG2—Tamoxifen—pancreatic cancer	0.0112	0.045	CbGbCtD
Mitoxantrone—CYP2E1—Dacarbazine—pancreatic cancer	0.01	0.0403	CbGbCtD
Mitoxantrone—CYP1B1—Doxorubicin—pancreatic cancer	0.00987	0.0397	CbGbCtD
Mitoxantrone—ABCG2—Erlotinib—pancreatic cancer	0.00951	0.0382	CbGbCtD
Mitoxantrone—ABCC1—Docetaxel—pancreatic cancer	0.00941	0.0378	CbGbCtD
Mitoxantrone—ABCG2—Irinotecan—pancreatic cancer	0.00859	0.0345	CbGbCtD
Mitoxantrone—ABCG2—Fluorouracil—pancreatic cancer	0.00824	0.0331	CbGbCtD
Mitoxantrone—CYP2E1—Tamoxifen—pancreatic cancer	0.00797	0.0321	CbGbCtD
Mitoxantrone—ABCC1—Doxorubicin—pancreatic cancer	0.00701	0.0282	CbGbCtD
Mitoxantrone—ABCG2—Docetaxel—pancreatic cancer	0.00629	0.0253	CbGbCtD
Mitoxantrone—ABCG2—Sunitinib—pancreatic cancer	0.00627	0.0252	CbGbCtD
Mitoxantrone—ABCG2—Doxorubicin—pancreatic cancer	0.00469	0.0189	CbGbCtD
Mitoxantrone—ABCB1—Tamoxifen—pancreatic cancer	0.00403	0.0162	CbGbCtD
Mitoxantrone—ABCB1—Gemcitabine—pancreatic cancer	0.00347	0.014	CbGbCtD
Mitoxantrone—ABCB1—Erlotinib—pancreatic cancer	0.00343	0.0138	CbGbCtD
Mitoxantrone—ABCB1—Irinotecan—pancreatic cancer	0.0031	0.0125	CbGbCtD
Mitoxantrone—CYP3A4—Tamoxifen—pancreatic cancer	0.00242	0.00972	CbGbCtD
Mitoxantrone—ABCB1—Docetaxel—pancreatic cancer	0.00227	0.00913	CbGbCtD
Mitoxantrone—ABCB1—Sunitinib—pancreatic cancer	0.00226	0.00909	CbGbCtD
Mitoxantrone—CYP3A4—Erlotinib—pancreatic cancer	0.00205	0.00826	CbGbCtD
Mitoxantrone—CYP3A4—Irinotecan—pancreatic cancer	0.00186	0.00746	CbGbCtD
Mitoxantrone—ABCB1—Doxorubicin—pancreatic cancer	0.00169	0.0068	CbGbCtD
Mitoxantrone—CYP3A4—Docetaxel—pancreatic cancer	0.00136	0.00547	CbGbCtD
Mitoxantrone—CYP3A4—Sunitinib—pancreatic cancer	0.00135	0.00544	CbGbCtD
Mitoxantrone—CYP3A4—Doxorubicin—pancreatic cancer	0.00101	0.00408	CbGbCtD
Mitoxantrone—TOP2A—Topotecan—Irinotecan—pancreatic cancer	0.00031	0.24	CbGdCrCtD
Mitoxantrone—TOP2A—Paclitaxel—Docetaxel—pancreatic cancer	0.000218	0.168	CbGdCrCtD
Mitoxantrone—TOP2A—Gefitinib—Erlotinib—pancreatic cancer	0.000209	0.162	CbGdCrCtD
Mitoxantrone—TOP2A—Cytarabine—Gemcitabine—pancreatic cancer	7.87e-05	0.0608	CbGdCrCtD
Mitoxantrone—TOP2A—Doxorubicin—Epirubicin—pancreatic cancer	7.3e-05	0.0564	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Epirubicin—pancreatic cancer	7.3e-05	0.0564	CbGdCrCtD
Mitoxantrone—TOP2A—Daunorubicin—Epirubicin—pancreatic cancer	7.3e-05	0.0564	CbGdCrCtD
Mitoxantrone—TOP2A—Daunorubicin—Doxorubicin—pancreatic cancer	6.75e-05	0.0522	CbGdCrCtD
Mitoxantrone—TOP2A—Epirubicin—Doxorubicin—pancreatic cancer	6.75e-05	0.0522	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Doxorubicin—pancreatic cancer	6.75e-05	0.0522	CbGdCrCtD
Mitoxantrone—TOP2A—Azacitidine—Gemcitabine—pancreatic cancer	5.64e-05	0.0436	CbGdCrCtD
Mitoxantrone—Pain—Irinotecan—pancreatic cancer	4.11e-05	0.000571	CcSEcCtD
Mitoxantrone—Constipation—Irinotecan—pancreatic cancer	4.11e-05	0.000571	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	4.11e-05	0.00057	CcSEcCtD
Mitoxantrone—Dyspnoea—Fluorouracil—pancreatic cancer	4.11e-05	0.00057	CcSEcCtD
Mitoxantrone—Somnolence—Fluorouracil—pancreatic cancer	4.09e-05	0.000568	CcSEcCtD
Mitoxantrone—Erythema—Docetaxel—pancreatic cancer	4.07e-05	0.000565	CcSEcCtD
Mitoxantrone—Decreased appetite—Gemcitabine—pancreatic cancer	4.07e-05	0.000565	CcSEcCtD
Mitoxantrone—Dyspepsia—Fluorouracil—pancreatic cancer	4.05e-05	0.000563	CcSEcCtD
Mitoxantrone—Nausea—Tamoxifen—pancreatic cancer	4.05e-05	0.000562	CcSEcCtD
Mitoxantrone—Fatigue—Gemcitabine—pancreatic cancer	4.04e-05	0.00056	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	4.02e-05	0.000558	CcSEcCtD
Mitoxantrone—Constipation—Gemcitabine—pancreatic cancer	4.01e-05	0.000556	CcSEcCtD
Mitoxantrone—Pain—Gemcitabine—pancreatic cancer	4.01e-05	0.000556	CcSEcCtD
Mitoxantrone—Nausea—Erlotinib—pancreatic cancer	4.01e-05	0.000556	CcSEcCtD
Mitoxantrone—Decreased appetite—Fluorouracil—pancreatic cancer	4e-05	0.000556	CcSEcCtD
Mitoxantrone—Diarrhoea—Sunitinib—pancreatic cancer	3.99e-05	0.000554	CcSEcCtD
Mitoxantrone—Dysgeusia—Docetaxel—pancreatic cancer	3.99e-05	0.000554	CcSEcCtD
Mitoxantrone—Feeling abnormal—Irinotecan—pancreatic cancer	3.96e-05	0.00055	CcSEcCtD
Mitoxantrone—Blood creatinine increased—Doxorubicin—pancreatic cancer	3.95e-05	0.000549	CcSEcCtD
Mitoxantrone—Back pain—Docetaxel—pancreatic cancer	3.94e-05	0.000547	CcSEcCtD
Mitoxantrone—Pain—Fluorouracil—pancreatic cancer	3.94e-05	0.000547	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Irinotecan—pancreatic cancer	3.93e-05	0.000546	CcSEcCtD
Mitoxantrone—Dehydration—Doxorubicin—pancreatic cancer	3.93e-05	0.000545	CcSEcCtD
Mitoxantrone—Feeling abnormal—Gemcitabine—pancreatic cancer	3.86e-05	0.000536	CcSEcCtD
Mitoxantrone—Abdominal pain upper—Doxorubicin—pancreatic cancer	3.86e-05	0.000535	CcSEcCtD
Mitoxantrone—Hypokalaemia—Doxorubicin—pancreatic cancer	3.84e-05	0.000533	CcSEcCtD
Mitoxantrone—Body temperature increased—Irinotecan—pancreatic cancer	3.8e-05	0.000528	CcSEcCtD
Mitoxantrone—Abdominal pain—Irinotecan—pancreatic cancer	3.8e-05	0.000528	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	3.8e-05	0.000528	CcSEcCtD
Mitoxantrone—Feeling abnormal—Fluorouracil—pancreatic cancer	3.8e-05	0.000527	CcSEcCtD
Mitoxantrone—Anaemia—Docetaxel—pancreatic cancer	3.76e-05	0.000522	CcSEcCtD
Mitoxantrone—Pancytopenia—Epirubicin—pancreatic cancer	3.74e-05	0.00052	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	3.72e-05	0.000517	CcSEcCtD
Mitoxantrone—Vomiting—Sunitinib—pancreatic cancer	3.71e-05	0.000515	CcSEcCtD
Mitoxantrone—Body temperature increased—Gemcitabine—pancreatic cancer	3.7e-05	0.000514	CcSEcCtD
Mitoxantrone—Neutropenia—Epirubicin—pancreatic cancer	3.69e-05	0.000512	CcSEcCtD
Mitoxantrone—Rash—Sunitinib—pancreatic cancer	3.68e-05	0.000511	CcSEcCtD
Mitoxantrone—Dermatitis—Sunitinib—pancreatic cancer	3.68e-05	0.00051	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Epirubicin—pancreatic cancer	3.66e-05	0.000509	CcSEcCtD
Mitoxantrone—Urticaria—Fluorouracil—pancreatic cancer	3.66e-05	0.000508	CcSEcCtD
Mitoxantrone—Headache—Sunitinib—pancreatic cancer	3.66e-05	0.000508	CcSEcCtD
Mitoxantrone—Leukopenia—Docetaxel—pancreatic cancer	3.65e-05	0.000506	CcSEcCtD
Mitoxantrone—Body temperature increased—Fluorouracil—pancreatic cancer	3.64e-05	0.000505	CcSEcCtD
Mitoxantrone—Weight increased—Epirubicin—pancreatic cancer	3.59e-05	0.000498	CcSEcCtD
Mitoxantrone—Weight decreased—Epirubicin—pancreatic cancer	3.57e-05	0.000495	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Epirubicin—pancreatic cancer	3.56e-05	0.000494	CcSEcCtD
Mitoxantrone—Cough—Docetaxel—pancreatic cancer	3.55e-05	0.000493	CcSEcCtD
Mitoxantrone—Hypersensitivity—Irinotecan—pancreatic cancer	3.54e-05	0.000492	CcSEcCtD
Mitoxantrone—Pneumonia—Epirubicin—pancreatic cancer	3.54e-05	0.000491	CcSEcCtD
Mitoxantrone—Convulsion—Docetaxel—pancreatic cancer	3.53e-05	0.00049	CcSEcCtD
Mitoxantrone—Hypertension—Docetaxel—pancreatic cancer	3.52e-05	0.000488	CcSEcCtD
Mitoxantrone—Drowsiness—Epirubicin—pancreatic cancer	3.52e-05	0.000488	CcSEcCtD
Mitoxantrone—Arthralgia—Docetaxel—pancreatic cancer	3.47e-05	0.000481	CcSEcCtD
Mitoxantrone—Chest pain—Docetaxel—pancreatic cancer	3.47e-05	0.000481	CcSEcCtD
Mitoxantrone—Myalgia—Docetaxel—pancreatic cancer	3.47e-05	0.000481	CcSEcCtD
Mitoxantrone—Nausea—Sunitinib—pancreatic cancer	3.47e-05	0.000481	CcSEcCtD
Mitoxantrone—Pancytopenia—Doxorubicin—pancreatic cancer	3.46e-05	0.000481	CcSEcCtD
Mitoxantrone—Renal failure—Epirubicin—pancreatic cancer	3.46e-05	0.00048	CcSEcCtD
Mitoxantrone—Asthenia—Irinotecan—pancreatic cancer	3.45e-05	0.000479	CcSEcCtD
Mitoxantrone—Stomatitis—Epirubicin—pancreatic cancer	3.43e-05	0.000476	CcSEcCtD
Mitoxantrone—Jaundice—Epirubicin—pancreatic cancer	3.43e-05	0.000476	CcSEcCtD
Mitoxantrone—Conjunctivitis—Epirubicin—pancreatic cancer	3.42e-05	0.000474	CcSEcCtD
Mitoxantrone—Urinary tract infection—Epirubicin—pancreatic cancer	3.42e-05	0.000474	CcSEcCtD
Mitoxantrone—Neutropenia—Doxorubicin—pancreatic cancer	3.41e-05	0.000473	CcSEcCtD
Mitoxantrone—Hypersensitivity—Fluorouracil—pancreatic cancer	3.39e-05	0.000471	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	3.39e-05	0.000471	CcSEcCtD
Mitoxantrone—Sweating—Epirubicin—pancreatic cancer	3.37e-05	0.000468	CcSEcCtD
Mitoxantrone—Asthenia—Gemcitabine—pancreatic cancer	3.36e-05	0.000466	CcSEcCtD
Mitoxantrone—Haematuria—Epirubicin—pancreatic cancer	3.35e-05	0.000465	CcSEcCtD
Mitoxantrone—Confusional state—Docetaxel—pancreatic cancer	3.35e-05	0.000465	CcSEcCtD
Mitoxantrone—Oedema—Docetaxel—pancreatic cancer	3.32e-05	0.000461	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Docetaxel—pancreatic cancer	3.32e-05	0.000461	CcSEcCtD
Mitoxantrone—Weight increased—Doxorubicin—pancreatic cancer	3.32e-05	0.000461	CcSEcCtD
Mitoxantrone—Infection—Docetaxel—pancreatic cancer	3.3e-05	0.000458	CcSEcCtD
Mitoxantrone—Weight decreased—Doxorubicin—pancreatic cancer	3.3e-05	0.000458	CcSEcCtD
Mitoxantrone—Sinusitis—Epirubicin—pancreatic cancer	3.3e-05	0.000458	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Doxorubicin—pancreatic cancer	3.29e-05	0.000457	CcSEcCtD
Mitoxantrone—Diarrhoea—Irinotecan—pancreatic cancer	3.29e-05	0.000457	CcSEcCtD
Mitoxantrone—Agranulocytosis—Epirubicin—pancreatic cancer	3.28e-05	0.000455	CcSEcCtD
Mitoxantrone—Pneumonia—Doxorubicin—pancreatic cancer	3.27e-05	0.000454	CcSEcCtD
Mitoxantrone—Shock—Docetaxel—pancreatic cancer	3.27e-05	0.000454	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Docetaxel—pancreatic cancer	3.25e-05	0.000452	CcSEcCtD
Mitoxantrone—Drowsiness—Doxorubicin—pancreatic cancer	3.25e-05	0.000451	CcSEcCtD
Mitoxantrone—Tachycardia—Docetaxel—pancreatic cancer	3.24e-05	0.00045	CcSEcCtD
Mitoxantrone—Skin disorder—Docetaxel—pancreatic cancer	3.23e-05	0.000448	CcSEcCtD
Mitoxantrone—Bradycardia—Epirubicin—pancreatic cancer	3.21e-05	0.000446	CcSEcCtD
Mitoxantrone—Diarrhoea—Gemcitabine—pancreatic cancer	3.21e-05	0.000445	CcSEcCtD
Mitoxantrone—Renal failure—Doxorubicin—pancreatic cancer	3.2e-05	0.000444	CcSEcCtD
Mitoxantrone—Haemoglobin—Epirubicin—pancreatic cancer	3.17e-05	0.00044	CcSEcCtD
Mitoxantrone—Jaundice—Doxorubicin—pancreatic cancer	3.17e-05	0.00044	CcSEcCtD
Mitoxantrone—Stomatitis—Doxorubicin—pancreatic cancer	3.17e-05	0.00044	CcSEcCtD
Mitoxantrone—Anorexia—Docetaxel—pancreatic cancer	3.17e-05	0.00044	CcSEcCtD
Mitoxantrone—Rhinitis—Epirubicin—pancreatic cancer	3.16e-05	0.000439	CcSEcCtD
Mitoxantrone—Urinary tract infection—Doxorubicin—pancreatic cancer	3.16e-05	0.000439	CcSEcCtD
Mitoxantrone—Conjunctivitis—Doxorubicin—pancreatic cancer	3.16e-05	0.000439	CcSEcCtD
Mitoxantrone—Haemorrhage—Epirubicin—pancreatic cancer	3.16e-05	0.000438	CcSEcCtD
Mitoxantrone—Hepatitis—Epirubicin—pancreatic cancer	3.16e-05	0.000438	CcSEcCtD
Mitoxantrone—Diarrhoea—Fluorouracil—pancreatic cancer	3.15e-05	0.000437	CcSEcCtD
Mitoxantrone—Pharyngitis—Epirubicin—pancreatic cancer	3.13e-05	0.000435	CcSEcCtD
Mitoxantrone—Sweating—Doxorubicin—pancreatic cancer	3.12e-05	0.000433	CcSEcCtD
Mitoxantrone—Hypotension—Docetaxel—pancreatic cancer	3.11e-05	0.000431	CcSEcCtD
Mitoxantrone—Haematuria—Doxorubicin—pancreatic cancer	3.1e-05	0.00043	CcSEcCtD
Mitoxantrone—Vomiting—Irinotecan—pancreatic cancer	3.06e-05	0.000424	CcSEcCtD
Mitoxantrone—Sinusitis—Doxorubicin—pancreatic cancer	3.05e-05	0.000424	CcSEcCtD
Mitoxantrone—Agranulocytosis—Doxorubicin—pancreatic cancer	3.04e-05	0.000421	CcSEcCtD
Mitoxantrone—Rash—Irinotecan—pancreatic cancer	3.03e-05	0.000421	CcSEcCtD
Mitoxantrone—Dermatitis—Irinotecan—pancreatic cancer	3.03e-05	0.00042	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	3.03e-05	0.00042	CcSEcCtD
Mitoxantrone—Headache—Irinotecan—pancreatic cancer	3.01e-05	0.000418	CcSEcCtD
Mitoxantrone—Paraesthesia—Docetaxel—pancreatic cancer	2.98e-05	0.000414	CcSEcCtD
Mitoxantrone—Vomiting—Gemcitabine—pancreatic cancer	2.98e-05	0.000413	CcSEcCtD
Mitoxantrone—Bradycardia—Doxorubicin—pancreatic cancer	2.97e-05	0.000413	CcSEcCtD
Mitoxantrone—Dyspnoea—Docetaxel—pancreatic cancer	2.96e-05	0.000411	CcSEcCtD
Mitoxantrone—Somnolence—Docetaxel—pancreatic cancer	2.96e-05	0.00041	CcSEcCtD
Mitoxantrone—Rash—Gemcitabine—pancreatic cancer	2.95e-05	0.00041	CcSEcCtD
Mitoxantrone—Dermatitis—Gemcitabine—pancreatic cancer	2.95e-05	0.00041	CcSEcCtD
Mitoxantrone—Haemoglobin—Doxorubicin—pancreatic cancer	2.93e-05	0.000407	CcSEcCtD
Mitoxantrone—Headache—Gemcitabine—pancreatic cancer	2.93e-05	0.000407	CcSEcCtD
Mitoxantrone—Vomiting—Fluorouracil—pancreatic cancer	2.93e-05	0.000406	CcSEcCtD
Mitoxantrone—Rhinitis—Doxorubicin—pancreatic cancer	2.93e-05	0.000406	CcSEcCtD
Mitoxantrone—Dyspepsia—Docetaxel—pancreatic cancer	2.93e-05	0.000406	CcSEcCtD
Mitoxantrone—Haemorrhage—Doxorubicin—pancreatic cancer	2.92e-05	0.000405	CcSEcCtD
Mitoxantrone—Hepatitis—Doxorubicin—pancreatic cancer	2.92e-05	0.000405	CcSEcCtD
Mitoxantrone—Rash—Fluorouracil—pancreatic cancer	2.9e-05	0.000403	CcSEcCtD
Mitoxantrone—Dermatitis—Fluorouracil—pancreatic cancer	2.9e-05	0.000403	CcSEcCtD
Mitoxantrone—Pharyngitis—Doxorubicin—pancreatic cancer	2.9e-05	0.000402	CcSEcCtD
Mitoxantrone—Decreased appetite—Docetaxel—pancreatic cancer	2.89e-05	0.000401	CcSEcCtD
Mitoxantrone—Headache—Fluorouracil—pancreatic cancer	2.89e-05	0.0004	CcSEcCtD
Mitoxantrone—Fatigue—Docetaxel—pancreatic cancer	2.87e-05	0.000398	CcSEcCtD
Mitoxantrone—Nausea—Irinotecan—pancreatic cancer	2.86e-05	0.000396	CcSEcCtD
Mitoxantrone—Constipation—Docetaxel—pancreatic cancer	2.84e-05	0.000395	CcSEcCtD
Mitoxantrone—Pain—Docetaxel—pancreatic cancer	2.84e-05	0.000395	CcSEcCtD
Mitoxantrone—Chills—Epirubicin—pancreatic cancer	2.83e-05	0.000393	CcSEcCtD
Mitoxantrone—Arrhythmia—Epirubicin—pancreatic cancer	2.82e-05	0.000391	CcSEcCtD
Mitoxantrone—Alopecia—Epirubicin—pancreatic cancer	2.79e-05	0.000387	CcSEcCtD
Mitoxantrone—Nausea—Gemcitabine—pancreatic cancer	2.78e-05	0.000386	CcSEcCtD
Mitoxantrone—Erythema—Epirubicin—pancreatic cancer	2.75e-05	0.000381	CcSEcCtD
Mitoxantrone—Feeling abnormal—Docetaxel—pancreatic cancer	2.74e-05	0.00038	CcSEcCtD
Mitoxantrone—Nausea—Fluorouracil—pancreatic cancer	2.74e-05	0.00038	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Docetaxel—pancreatic cancer	2.72e-05	0.000377	CcSEcCtD
Mitoxantrone—Dysgeusia—Epirubicin—pancreatic cancer	2.69e-05	0.000373	CcSEcCtD
Mitoxantrone—Back pain—Epirubicin—pancreatic cancer	2.66e-05	0.000369	CcSEcCtD
Mitoxantrone—Abdominal pain—Docetaxel—pancreatic cancer	2.63e-05	0.000365	CcSEcCtD
Mitoxantrone—Body temperature increased—Docetaxel—pancreatic cancer	2.63e-05	0.000365	CcSEcCtD
Mitoxantrone—Chills—Doxorubicin—pancreatic cancer	2.62e-05	0.000364	CcSEcCtD
Mitoxantrone—Arrhythmia—Doxorubicin—pancreatic cancer	2.61e-05	0.000362	CcSEcCtD
Mitoxantrone—Vision blurred—Epirubicin—pancreatic cancer	2.59e-05	0.000359	CcSEcCtD
Mitoxantrone—Alopecia—Doxorubicin—pancreatic cancer	2.58e-05	0.000358	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Epirubicin—pancreatic cancer	2.55e-05	0.000354	CcSEcCtD
Mitoxantrone—Erythema—Doxorubicin—pancreatic cancer	2.54e-05	0.000353	CcSEcCtD
Mitoxantrone—Anaemia—Epirubicin—pancreatic cancer	2.54e-05	0.000352	CcSEcCtD
Mitoxantrone—Dysgeusia—Doxorubicin—pancreatic cancer	2.49e-05	0.000345	CcSEcCtD
Mitoxantrone—Malaise—Epirubicin—pancreatic cancer	2.48e-05	0.000344	CcSEcCtD
Mitoxantrone—Leukopenia—Epirubicin—pancreatic cancer	2.46e-05	0.000341	CcSEcCtD
Mitoxantrone—Back pain—Doxorubicin—pancreatic cancer	2.46e-05	0.000341	CcSEcCtD
Mitoxantrone—Hypersensitivity—Docetaxel—pancreatic cancer	2.45e-05	0.00034	CcSEcCtD
Mitoxantrone—Cough—Epirubicin—pancreatic cancer	2.4e-05	0.000333	CcSEcCtD
Mitoxantrone—Vision blurred—Doxorubicin—pancreatic cancer	2.4e-05	0.000332	CcSEcCtD
Mitoxantrone—Asthenia—Docetaxel—pancreatic cancer	2.39e-05	0.000331	CcSEcCtD
Mitoxantrone—Convulsion—Epirubicin—pancreatic cancer	2.38e-05	0.00033	CcSEcCtD
Mitoxantrone—Hypertension—Epirubicin—pancreatic cancer	2.37e-05	0.000329	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Doxorubicin—pancreatic cancer	2.36e-05	0.000327	CcSEcCtD
Mitoxantrone—Anaemia—Doxorubicin—pancreatic cancer	2.35e-05	0.000326	CcSEcCtD
Mitoxantrone—Myalgia—Epirubicin—pancreatic cancer	2.34e-05	0.000325	CcSEcCtD
Mitoxantrone—Chest pain—Epirubicin—pancreatic cancer	2.34e-05	0.000325	CcSEcCtD
Mitoxantrone—Arthralgia—Epirubicin—pancreatic cancer	2.34e-05	0.000325	CcSEcCtD
Mitoxantrone—Anxiety—Epirubicin—pancreatic cancer	2.33e-05	0.000323	CcSEcCtD
Mitoxantrone—Discomfort—Epirubicin—pancreatic cancer	2.31e-05	0.000321	CcSEcCtD
Mitoxantrone—Malaise—Doxorubicin—pancreatic cancer	2.29e-05	0.000318	CcSEcCtD
Mitoxantrone—Leukopenia—Doxorubicin—pancreatic cancer	2.28e-05	0.000316	CcSEcCtD
Mitoxantrone—Diarrhoea—Docetaxel—pancreatic cancer	2.27e-05	0.000316	CcSEcCtD
Mitoxantrone—Confusional state—Epirubicin—pancreatic cancer	2.26e-05	0.000314	CcSEcCtD
Mitoxantrone—Oedema—Epirubicin—pancreatic cancer	2.24e-05	0.000311	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Epirubicin—pancreatic cancer	2.24e-05	0.000311	CcSEcCtD
Mitoxantrone—Infection—Epirubicin—pancreatic cancer	2.23e-05	0.000309	CcSEcCtD
Mitoxantrone—Cough—Doxorubicin—pancreatic cancer	2.22e-05	0.000308	CcSEcCtD
Mitoxantrone—Shock—Epirubicin—pancreatic cancer	2.21e-05	0.000306	CcSEcCtD
Mitoxantrone—Convulsion—Doxorubicin—pancreatic cancer	2.2e-05	0.000306	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Epirubicin—pancreatic cancer	2.2e-05	0.000305	CcSEcCtD
Mitoxantrone—Hypertension—Doxorubicin—pancreatic cancer	2.19e-05	0.000305	CcSEcCtD
Mitoxantrone—Tachycardia—Epirubicin—pancreatic cancer	2.19e-05	0.000304	CcSEcCtD
Mitoxantrone—Skin disorder—Epirubicin—pancreatic cancer	2.18e-05	0.000302	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Epirubicin—pancreatic cancer	2.17e-05	0.000301	CcSEcCtD
Mitoxantrone—Chest pain—Doxorubicin—pancreatic cancer	2.16e-05	0.0003	CcSEcCtD
Mitoxantrone—Myalgia—Doxorubicin—pancreatic cancer	2.16e-05	0.0003	CcSEcCtD
Mitoxantrone—Arthralgia—Doxorubicin—pancreatic cancer	2.16e-05	0.0003	CcSEcCtD
Mitoxantrone—Anxiety—Doxorubicin—pancreatic cancer	2.16e-05	0.000299	CcSEcCtD
Mitoxantrone—Discomfort—Doxorubicin—pancreatic cancer	2.14e-05	0.000297	CcSEcCtD
Mitoxantrone—Anorexia—Epirubicin—pancreatic cancer	2.14e-05	0.000297	CcSEcCtD
Mitoxantrone—Vomiting—Docetaxel—pancreatic cancer	2.11e-05	0.000293	CcSEcCtD
Mitoxantrone—Rash—Docetaxel—pancreatic cancer	2.1e-05	0.000291	CcSEcCtD
Mitoxantrone—Hypotension—Epirubicin—pancreatic cancer	2.1e-05	0.000291	CcSEcCtD
Mitoxantrone—Dermatitis—Docetaxel—pancreatic cancer	2.09e-05	0.000291	CcSEcCtD
Mitoxantrone—Confusional state—Doxorubicin—pancreatic cancer	2.09e-05	0.00029	CcSEcCtD
Mitoxantrone—Headache—Docetaxel—pancreatic cancer	2.08e-05	0.000289	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Doxorubicin—pancreatic cancer	2.07e-05	0.000288	CcSEcCtD
Mitoxantrone—Oedema—Doxorubicin—pancreatic cancer	2.07e-05	0.000288	CcSEcCtD
Mitoxantrone—Infection—Doxorubicin—pancreatic cancer	2.06e-05	0.000286	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	2.04e-05	0.000284	CcSEcCtD
Mitoxantrone—Shock—Doxorubicin—pancreatic cancer	2.04e-05	0.000283	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Doxorubicin—pancreatic cancer	2.03e-05	0.000282	CcSEcCtD
Mitoxantrone—Tachycardia—Doxorubicin—pancreatic cancer	2.02e-05	0.000281	CcSEcCtD
Mitoxantrone—Skin disorder—Doxorubicin—pancreatic cancer	2.02e-05	0.00028	CcSEcCtD
Mitoxantrone—Paraesthesia—Epirubicin—pancreatic cancer	2.01e-05	0.000279	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Doxorubicin—pancreatic cancer	2.01e-05	0.000278	CcSEcCtD
Mitoxantrone—Dyspnoea—Epirubicin—pancreatic cancer	2e-05	0.000277	CcSEcCtD
Mitoxantrone—Somnolence—Epirubicin—pancreatic cancer	1.99e-05	0.000277	CcSEcCtD
Mitoxantrone—Anorexia—Doxorubicin—pancreatic cancer	1.98e-05	0.000274	CcSEcCtD
Mitoxantrone—Nausea—Docetaxel—pancreatic cancer	1.97e-05	0.000274	CcSEcCtD
Mitoxantrone—Dyspepsia—Epirubicin—pancreatic cancer	1.97e-05	0.000274	CcSEcCtD
Mitoxantrone—Decreased appetite—Epirubicin—pancreatic cancer	1.95e-05	0.000271	CcSEcCtD
Mitoxantrone—Hypotension—Doxorubicin—pancreatic cancer	1.94e-05	0.000269	CcSEcCtD
Mitoxantrone—Fatigue—Epirubicin—pancreatic cancer	1.93e-05	0.000268	CcSEcCtD
Mitoxantrone—Constipation—Epirubicin—pancreatic cancer	1.92e-05	0.000266	CcSEcCtD
Mitoxantrone—Pain—Epirubicin—pancreatic cancer	1.92e-05	0.000266	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	1.89e-05	0.000262	CcSEcCtD
Mitoxantrone—Paraesthesia—Doxorubicin—pancreatic cancer	1.86e-05	0.000259	CcSEcCtD
Mitoxantrone—Dyspnoea—Doxorubicin—pancreatic cancer	1.85e-05	0.000257	CcSEcCtD
Mitoxantrone—Feeling abnormal—Epirubicin—pancreatic cancer	1.85e-05	0.000256	CcSEcCtD
Mitoxantrone—Somnolence—Doxorubicin—pancreatic cancer	1.84e-05	0.000256	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Epirubicin—pancreatic cancer	1.83e-05	0.000254	CcSEcCtD
Mitoxantrone—Dyspepsia—Doxorubicin—pancreatic cancer	1.83e-05	0.000253	CcSEcCtD
Mitoxantrone—Decreased appetite—Doxorubicin—pancreatic cancer	1.8e-05	0.00025	CcSEcCtD
Mitoxantrone—Fatigue—Doxorubicin—pancreatic cancer	1.79e-05	0.000248	CcSEcCtD
Mitoxantrone—Urticaria—Epirubicin—pancreatic cancer	1.78e-05	0.000247	CcSEcCtD
Mitoxantrone—Pain—Doxorubicin—pancreatic cancer	1.77e-05	0.000246	CcSEcCtD
Mitoxantrone—Constipation—Doxorubicin—pancreatic cancer	1.77e-05	0.000246	CcSEcCtD
Mitoxantrone—Body temperature increased—Epirubicin—pancreatic cancer	1.77e-05	0.000246	CcSEcCtD
Mitoxantrone—Abdominal pain—Epirubicin—pancreatic cancer	1.77e-05	0.000246	CcSEcCtD
Mitoxantrone—Feeling abnormal—Doxorubicin—pancreatic cancer	1.71e-05	0.000237	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	1.7e-05	0.000235	CcSEcCtD
Mitoxantrone—Hypersensitivity—Epirubicin—pancreatic cancer	1.65e-05	0.000229	CcSEcCtD
Mitoxantrone—Urticaria—Doxorubicin—pancreatic cancer	1.65e-05	0.000229	CcSEcCtD
Mitoxantrone—Body temperature increased—Doxorubicin—pancreatic cancer	1.64e-05	0.000228	CcSEcCtD
Mitoxantrone—Abdominal pain—Doxorubicin—pancreatic cancer	1.64e-05	0.000228	CcSEcCtD
Mitoxantrone—Asthenia—Epirubicin—pancreatic cancer	1.61e-05	0.000223	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.53e-05	0.0006	CbGpPWpGaD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	1.53e-05	0.000599	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Epirubicin—pancreatic cancer	1.53e-05	0.000213	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—PIK3CD—pancreatic cancer	1.53e-05	0.000597	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Doxorubicin—pancreatic cancer	1.53e-05	0.000212	CcSEcCtD
Mitoxantrone—Asthenia—Doxorubicin—pancreatic cancer	1.49e-05	0.000207	CcSEcCtD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	1.49e-05	0.000581	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TERT—pancreatic cancer	1.47e-05	0.000572	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.46e-05	0.000571	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PRSS1—pancreatic cancer	1.46e-05	0.000571	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.45e-05	0.000566	CbGpPWpGaD
Mitoxantrone—Vomiting—Epirubicin—pancreatic cancer	1.43e-05	0.000198	CcSEcCtD
Mitoxantrone—Diarrhoea—Doxorubicin—pancreatic cancer	1.42e-05	0.000197	CcSEcCtD
Mitoxantrone—Rash—Epirubicin—pancreatic cancer	1.41e-05	0.000196	CcSEcCtD
Mitoxantrone—CYP1B1—Metabolism—PRSS1—pancreatic cancer	1.41e-05	0.000552	CbGpPWpGaD
Mitoxantrone—Dermatitis—Epirubicin—pancreatic cancer	1.41e-05	0.000196	CcSEcCtD
Mitoxantrone—Headache—Epirubicin—pancreatic cancer	1.4e-05	0.000195	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	1.4e-05	0.000547	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PIK3CB—pancreatic cancer	1.39e-05	0.000542	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	1.35e-05	0.000525	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	1.34e-05	0.000524	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PIK3CB—pancreatic cancer	1.33e-05	0.000521	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.33e-05	0.00052	CbGpPWpGaD
Mitoxantrone—Nausea—Epirubicin—pancreatic cancer	1.33e-05	0.000185	CcSEcCtD
Mitoxantrone—ABCC1—Disease—DTX4—pancreatic cancer	1.32e-05	0.000516	CbGpPWpGaD
Mitoxantrone—Vomiting—Doxorubicin—pancreatic cancer	1.32e-05	0.000183	CcSEcCtD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	1.31e-05	0.000513	CbGpPWpGaD
Mitoxantrone—Rash—Doxorubicin—pancreatic cancer	1.31e-05	0.000182	CcSEcCtD
Mitoxantrone—Dermatitis—Doxorubicin—pancreatic cancer	1.31e-05	0.000181	CcSEcCtD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	1.3e-05	0.000509	CbGpPWpGaD
Mitoxantrone—Headache—Doxorubicin—pancreatic cancer	1.3e-05	0.00018	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.29e-05	0.000503	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PPP2R5B—pancreatic cancer	1.29e-05	0.000502	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PRSS1—pancreatic cancer	1.29e-05	0.000502	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	1.28e-05	0.0005	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—RB1—pancreatic cancer	1.28e-05	0.000498	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ARG2—pancreatic cancer	1.27e-05	0.000495	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HEY2—pancreatic cancer	1.24e-05	0.000483	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—TP53—pancreatic cancer	1.24e-05	0.000483	CbGpPWpGaD
Mitoxantrone—Nausea—Doxorubicin—pancreatic cancer	1.23e-05	0.000171	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—CTNNB1—pancreatic cancer	1.23e-05	0.000481	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ARG2—pancreatic cancer	1.22e-05	0.000478	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—BCL2L1—pancreatic cancer	1.2e-05	0.00047	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PTEN—pancreatic cancer	1.2e-05	0.000468	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TSC2—pancreatic cancer	1.19e-05	0.000467	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PTEN—pancreatic cancer	1.15e-05	0.00045	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HEY1—pancreatic cancer	1.15e-05	0.000448	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—RB1—pancreatic cancer	1.14e-05	0.000445	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	1.14e-05	0.000445	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	1.12e-05	0.000438	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ARG2—pancreatic cancer	1.11e-05	0.000435	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—SRC—pancreatic cancer	1.11e-05	0.000434	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TYMP—pancreatic cancer	1.11e-05	0.000432	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NFKBIA—pancreatic cancer	1.09e-05	0.000426	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.09e-05	0.000425	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TYMP—pancreatic cancer	1.07e-05	0.000418	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—NRAS—pancreatic cancer	1.07e-05	0.000418	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—SRC—pancreatic cancer	1.07e-05	0.000417	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	1.04e-05	0.000408	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—EGF—pancreatic cancer	1.04e-05	0.000407	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—NRAS—pancreatic cancer	1.03e-05	0.000401	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—JAG2—pancreatic cancer	1.02e-05	0.000397	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN2A—pancreatic cancer	1e-05	0.000392	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MEN1—pancreatic cancer	1e-05	0.000391	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SLC2A2—pancreatic cancer	9.94e-06	0.000389	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TNF—pancreatic cancer	9.75e-06	0.000381	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—EGFR—pancreatic cancer	9.75e-06	0.000381	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TYMP—pancreatic cancer	9.74e-06	0.00038	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDH1—pancreatic cancer	9.71e-06	0.000379	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	9.7e-06	0.000379	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SHH—pancreatic cancer	9.55e-06	0.000373	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CCND1—pancreatic cancer	9.47e-06	0.00037	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IAPP—pancreatic cancer	9.44e-06	0.000369	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—EGFR—pancreatic cancer	9.36e-06	0.000366	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	9.28e-06	0.000363	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CD—pancreatic cancer	9.27e-06	0.000362	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PRSS1—pancreatic cancer	9.23e-06	0.00036	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—KRAS—pancreatic cancer	9.21e-06	0.00036	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.13e-06	0.000357	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HSPA1B—pancreatic cancer	9.06e-06	0.000354	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GLP1R—pancreatic cancer	8.92e-06	0.000349	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—KRAS—pancreatic cancer	8.84e-06	0.000345	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.83e-06	0.000345	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—DPYD—pancreatic cancer	8.78e-06	0.000343	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GLP1R—pancreatic cancer	8.63e-06	0.000337	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—DPYD—pancreatic cancer	8.49e-06	0.000332	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CCND1—pancreatic cancer	8.47e-06	0.000331	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PIK3CA—pancreatic cancer	8.46e-06	0.00033	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	8.46e-06	0.00033	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	8.38e-06	0.000328	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SLC2A2—pancreatic cancer	8.33e-06	0.000325	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.24e-06	0.000322	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PIK3CA—pancreatic cancer	8.12e-06	0.000317	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—JAG1—pancreatic cancer	8.11e-06	0.000317	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CB—pancreatic cancer	8.08e-06	0.000316	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SLC2A2—pancreatic cancer	8.06e-06	0.000315	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ARG2—pancreatic cancer	8e-06	0.000313	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.97e-06	0.000311	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.95e-06	0.000311	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GLP1R—pancreatic cancer	7.85e-06	0.000307	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—HRAS—pancreatic cancer	7.83e-06	0.000306	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—DPYD—pancreatic cancer	7.72e-06	0.000302	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD44—pancreatic cancer	7.7e-06	0.000301	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.69e-06	0.000301	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HSPA1A—pancreatic cancer	7.65e-06	0.000299	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MYC—pancreatic cancer	7.6e-06	0.000297	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HRAS—pancreatic cancer	7.52e-06	0.000294	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SLC2A2—pancreatic cancer	7.33e-06	0.000286	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.25e-06	0.000283	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CTNNB1—pancreatic cancer	7.17e-06	0.00028	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	7.13e-06	0.000279	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.01e-06	0.000274	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TYMP—pancreatic cancer	6.99e-06	0.000273	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PTEN—pancreatic cancer	6.98e-06	0.000273	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PRSS1—pancreatic cancer	6.95e-06	0.000271	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—AKT1—pancreatic cancer	6.91e-06	0.00027	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MYC—pancreatic cancer	6.79e-06	0.000265	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—AKT1—pancreatic cancer	6.64e-06	0.000259	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	6.62e-06	0.000259	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—SRC—pancreatic cancer	6.48e-06	0.000253	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CD44—pancreatic cancer	6.45e-06	0.000252	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	6.44e-06	0.000252	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	6.38e-06	0.000249	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.32e-06	0.000247	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.26e-06	0.000244	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—STAT3—pancreatic cancer	6.25e-06	0.000244	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CD44—pancreatic cancer	6.24e-06	0.000244	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NRAS—pancreatic cancer	6.23e-06	0.000243	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	6.22e-06	0.000243	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GCG—pancreatic cancer	6.18e-06	0.000242	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.11e-06	0.000239	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SMAD4—pancreatic cancer	6.08e-06	0.000238	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.05e-06	0.000236	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ARG2—pancreatic cancer	6.02e-06	0.000235	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GCG—pancreatic cancer	5.98e-06	0.000234	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HES1—pancreatic cancer	5.94e-06	0.000232	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—STK11—pancreatic cancer	5.81e-06	0.000227	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	5.77e-06	0.000225	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—EGFR—pancreatic cancer	5.68e-06	0.000222	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CD44—pancreatic cancer	5.68e-06	0.000222	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GLP1R—pancreatic cancer	5.64e-06	0.00022	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—STK11—pancreatic cancer	5.62e-06	0.00022	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	5.62e-06	0.000219	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—pancreatic cancer	5.58e-06	0.000218	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—DPYD—pancreatic cancer	5.54e-06	0.000217	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.46e-06	0.000213	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GCG—pancreatic cancer	5.44e-06	0.000213	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—KRAS—pancreatic cancer	5.36e-06	0.00021	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.28e-06	0.000206	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TYMP—pancreatic cancer	5.27e-06	0.000206	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC2A2—pancreatic cancer	5.26e-06	0.000206	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TERT—pancreatic cancer	5.2e-06	0.000203	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	5.17e-06	0.000202	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	5.15e-06	0.000201	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—STK11—pancreatic cancer	5.12e-06	0.0002	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	5.05e-06	0.000197	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TYMS—pancreatic cancer	5e-06	0.000195	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HIF1A—pancreatic cancer	4.97e-06	0.000194	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TSC2—pancreatic cancer	4.96e-06	0.000194	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CA—pancreatic cancer	4.93e-06	0.000192	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APOE—pancreatic cancer	4.86e-06	0.00019	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TYMS—pancreatic cancer	4.84e-06	0.000189	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	4.81e-06	0.000188	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	4.77e-06	0.000187	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HRAS—pancreatic cancer	4.56e-06	0.000178	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOTCH1—pancreatic cancer	4.48e-06	0.000175	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TYMS—pancreatic cancer	4.4e-06	0.000172	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	4.39e-06	0.000171	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGF—pancreatic cancer	4.33e-06	0.000169	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PRSS1—pancreatic cancer	4.28e-06	0.000167	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GLP1R—pancreatic cancer	4.24e-06	0.000166	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	4.24e-06	0.000166	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—DPYD—pancreatic cancer	4.18e-06	0.000163	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CD44—pancreatic cancer	4.07e-06	0.000159	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—APOE—pancreatic cancer	4.07e-06	0.000159	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—AKT1—pancreatic cancer	4.03e-06	0.000157	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC2A2—pancreatic cancer	3.96e-06	0.000155	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—APOE—pancreatic cancer	3.93e-06	0.000154	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GCG—pancreatic cancer	3.91e-06	0.000153	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CD—pancreatic cancer	3.85e-06	0.000151	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.85e-06	0.00015	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.72e-06	0.000145	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ARG2—pancreatic cancer	3.71e-06	0.000145	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—STK11—pancreatic cancer	3.67e-06	0.000143	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CG—pancreatic cancer	3.67e-06	0.000143	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.58e-06	0.00014	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APOE—pancreatic cancer	3.58e-06	0.00014	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CG—pancreatic cancer	3.55e-06	0.000139	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPARG—pancreatic cancer	3.54e-06	0.000138	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPARG—pancreatic cancer	3.43e-06	0.000134	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CB—pancreatic cancer	3.36e-06	0.000131	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—pancreatic cancer	3.33e-06	0.00013	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.24e-06	0.000127	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CG—pancreatic cancer	3.23e-06	0.000126	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CD—pancreatic cancer	3.23e-06	0.000126	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TYMS—pancreatic cancer	3.16e-06	0.000123	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CD—pancreatic cancer	3.12e-06	0.000122	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPARG—pancreatic cancer	3.12e-06	0.000122	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CD44—pancreatic cancer	3.07e-06	0.00012	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CTNNB1—pancreatic cancer	2.98e-06	0.000116	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GCG—pancreatic cancer	2.94e-06	0.000115	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTEN—pancreatic cancer	2.9e-06	0.000113	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CD—pancreatic cancer	2.84e-06	0.000111	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CB—pancreatic cancer	2.81e-06	0.00011	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—pancreatic cancer	2.79e-06	0.000109	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—STK11—pancreatic cancer	2.77e-06	0.000108	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CB—pancreatic cancer	2.72e-06	0.000106	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—pancreatic cancer	2.7e-06	0.000105	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SRC—pancreatic cancer	2.69e-06	0.000105	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.61e-06	0.000102	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—STAT3—pancreatic cancer	2.6e-06	0.000101	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NRAS—pancreatic cancer	2.59e-06	0.000101	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.57e-06	0.0001	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOE—pancreatic cancer	2.57e-06	0.0001	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CB—pancreatic cancer	2.47e-06	9.67e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—pancreatic cancer	2.45e-06	9.58e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.44e-06	9.54e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTEN—pancreatic cancer	2.43e-06	9.49e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MYC—pancreatic cancer	2.41e-06	9.42e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TGFB1—pancreatic cancer	2.41e-06	9.4e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TYMS—pancreatic cancer	2.38e-06	9.29e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGFR—pancreatic cancer	2.36e-06	9.22e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTEN—pancreatic cancer	2.35e-06	9.18e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	2.32e-06	9.06e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPARG—pancreatic cancer	2.24e-06	8.74e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KRAS—pancreatic cancer	2.23e-06	8.71e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTEN—pancreatic cancer	2.14e-06	8.35e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CA—pancreatic cancer	2.05e-06	8e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	2.04e-06	7.96e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOE—pancreatic cancer	1.93e-06	7.56e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HRAS—pancreatic cancer	1.89e-06	7.4e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CD44—pancreatic cancer	1.89e-06	7.39e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GCG—pancreatic cancer	1.81e-06	7.08e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	1.78e-06	6.94e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—pancreatic cancer	1.76e-06	6.88e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.75e-06	6.82e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CA—pancreatic cancer	1.71e-06	6.7e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—STK11—pancreatic cancer	1.7e-06	6.66e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPARG—pancreatic cancer	1.69e-06	6.58e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT1—pancreatic cancer	1.67e-06	6.53e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CA—pancreatic cancer	1.66e-06	6.48e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTEN—pancreatic cancer	1.54e-06	6e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.54e-06	6e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CA—pancreatic cancer	1.51e-06	5.89e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.47e-06	5.73e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKT1—pancreatic cancer	1.4e-06	5.47e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKT1—pancreatic cancer	1.35e-06	5.29e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.34e-06	5.23e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.33e-06	5.18e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKT1—pancreatic cancer	1.23e-06	4.82e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOE—pancreatic cancer	1.19e-06	4.66e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTEN—pancreatic cancer	1.16e-06	4.52e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	1.08e-06	4.23e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.08e-06	4.2e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.04e-06	4.06e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	9.46e-07	3.7e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKT1—pancreatic cancer	8.85e-07	3.46e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	8.24e-07	3.22e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	8.17e-07	3.19e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CA—pancreatic cancer	8.16e-07	3.19e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTEN—pancreatic cancer	7.12e-07	2.78e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKT1—pancreatic cancer	6.66e-07	2.6e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	5.03e-07	1.96e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKT1—pancreatic cancer	4.11e-07	1.6e-05	CbGpPWpGaD
